Matches in Wikidata for { <http://www.wikidata.org/entity/Q91216069> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91216069 description "article scientifique publié en 2019" @default.
- Q91216069 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91216069 description "scientific article published on 24 January 2019" @default.
- Q91216069 description "wetenschappelijk artikel" @default.
- Q91216069 description "наукова стаття, опублікована 24 січня 2019" @default.
- Q91216069 name "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 name "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 type Item @default.
- Q91216069 label "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 label "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 prefLabel "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 prefLabel "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 P1433 Q91216069-B73E27DC-378A-43A2-BEC2-7C11089EE55A @default.
- Q91216069 P1476 Q91216069-8FD396F9-C366-44D1-A13A-1BC5934BE1C8 @default.
- Q91216069 P2093 Q91216069-077ED928-2034-49EB-B8C2-56D224F3D34A @default.
- Q91216069 P2093 Q91216069-1FE22561-099B-4E6F-9C85-4C08546ADE31 @default.
- Q91216069 P2093 Q91216069-30AF480E-13B5-4547-B91B-5EE74A2429FA @default.
- Q91216069 P2093 Q91216069-62249A23-B587-485E-BC6F-333343954280 @default.
- Q91216069 P2093 Q91216069-A967CD25-E1DB-481B-9F6B-ABFBD9240B06 @default.
- Q91216069 P2093 Q91216069-E1CDA84D-6DE0-4DD0-9A73-BCF4C46607DF @default.
- Q91216069 P304 Q91216069-C785256A-2A44-4221-9986-0239D9565D85 @default.
- Q91216069 P31 Q91216069-46A53841-827D-44E4-A63B-9ED4BC207C79 @default.
- Q91216069 P356 Q91216069-8C857341-7CD1-486E-B7A9-FFFE002E5932 @default.
- Q91216069 P433 Q91216069-D324269A-D203-459F-9E2D-37E09C4C503A @default.
- Q91216069 P478 Q91216069-91DE1E7E-1F47-437E-B0EA-4E2EE141623D @default.
- Q91216069 P50 Q91216069-33184028-6EAF-45F1-91AD-D55D55181285 @default.
- Q91216069 P577 Q91216069-5D12A011-BFB9-4B2C-A687-D2A6CE94FA8E @default.
- Q91216069 P698 Q91216069-4650991F-5631-4BF5-97C0-0D8E12E11564 @default.
- Q91216069 P921 Q91216069-02322E3B-2B5E-4610-B79A-775B5368EF93 @default.
- Q91216069 P356 ADMA.201805955 @default.
- Q91216069 P698 30680816 @default.
- Q91216069 P1433 Q1085159 @default.
- Q91216069 P1476 "Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors" @default.
- Q91216069 P2093 "Chenyang Hu" @default.
- Q91216069 P2093 "Dawei Zhang" @default.
- Q91216069 P2093 "Haiyang Yu" @default.
- Q91216069 P2093 "Na Shen" @default.
- Q91216069 P2093 "Shengcai Yang" @default.
- Q91216069 P2093 "Zhaohui Tang" @default.
- Q91216069 P304 "e1805955" @default.
- Q91216069 P31 Q13442814 @default.
- Q91216069 P356 "10.1002/ADMA.201805955" @default.
- Q91216069 P433 "11" @default.
- Q91216069 P478 "31" @default.
- Q91216069 P50 Q87642111 @default.
- Q91216069 P577 "2019-01-24T00:00:00Z" @default.
- Q91216069 P698 "30680816" @default.
- Q91216069 P921 Q261659 @default.